EMA concludes that adapted mRNA #COVID19vaccines targeting the original strain and Omicron BA.4-5 subvariants of the SARS-CoV-2 virus may be used for initial vaccination.

These #AdaptedVaccines are currently only authorised as boosters.

Find out more ⬇️ https://www.ema.europa.eu/en/news/etf-concludes-bivalent-original-omicron-ba4-5-mrna-vaccines-may-be-used-primary-vaccination

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600163966281547783